Browsing: Country

Flu shots are now available at selected Guardian, Unity, and Watsons pharmacies in Singapore in a new MOH trial to increase vaccination rates. Open to individuals 18 and above, these community locations aim to make flu vaccines more accessible for seniors and those at risk, supporting Singapore’s preventive care goals.

Log In or Register as a healthcare professional to read the full article.

His Majesty Sultan Ibrahim, alongside Health Minister Dr. Dzulkefly Ahmad, opened the MIH Megatrends 2024 in Kuala Lumpur. The event aims to drive forward-thinking solutions in healthcare and foster collaboration among Malaysia’s healthcare, business, and government sectors.

Malaysia’s MIH Megatrends 2024 gathers healthcare leaders, innovators, and policymakers worldwide to explore advancements in AI, robotics, and telemedicine. This three-day event, featuring public health screenings, family zones, and digital innovations, sets the stage for Malaysia’s role in ASEAN healthcare.

41 Doctors Investigated as MaNaDr Clinic Loses Licence The Ministry of Health (MOH) has initiated the revocation of MaNaDr Clinic’s…

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects movement, balance, and eye coordination, that afflicted the late Dr. Lee Wei Ling This article explores the symptoms, differences from Parkinson’s, and available management options for PSP.

Health advocates are urging the Department of Health (DOH) to expedite flu vaccine distribution due to a surge in influenza cases and the emergence of mpox. Experts warn that vulnerable populations, particularly the elderly, face increased risks as the rainy season exacerbates virus transmission

NEA expands Project Wolbachia in October 2024, releasing male Wolbachia-Aedes mosquitoes to five new areas to combat dengue. Despite the success of Project Wolbachia, the NEA emphasised that community participation remains crucial in preventing mosquito breeding.

Groundbreaking CD7 CAR-T therapy from NUS Medicine offers hope for T-cell acute lymphoblastic leukaemia (T-ALL) patients. Early case reports show 16 of 17 achieved remission, marking a significant cancer treatment advancement for relapsed/refractory T-ALL.

Three T-ALL patients – Viet Tai, Maria, and Hannah – share their inspiring cancer journeys through an innovative CD7 CAR-T therapy treatment, pioneered by researchers and clinicians from the NUS Medicine and NUHS and cultivated in-house by a modest laboratory in Singapore.